Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction

PURPOSE: The primary aim of this study was to assess treatment persistence with a fixed-dose combination (FDC) of tadalafil (5 mg) and tamsulosin (0.4 mg). This study also evaluated the reasons for early treatment discontinuation. MATERIALS AND METHODS: This retrospective observational study include...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Investig Clin Urol
Egile Nagusiak: Ahn, Sun Tae, Lee, Dong Hyun, Jeong, Hyeong Guk, Kim, Jong Wook, Oh, Mi Mi, Park, Hong Seok, Moon, Du Geon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Urological Association 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946826/
https://ncbi.nlm.nih.gov/pubmed/31942467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.1.81
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak